Drugplain

SUTENT 12.5 mg/1

Sunitinib malate · CAPSULE · U.S. Pharmaceuticals

2 Recalls on Record
Plain English

SUTENT is a capsule containing sunitinib malate at 12.5 mg/1, taken oral. Manufactured by U.S. Pharmaceuticals.

Key Facts

Brand Name
SUTENT
Generic Name
Sunitinib malate
NDC Code (Product)
63539-017
Manufacturer
U.S. Pharmaceuticals
Strength
12.5 mg/1
Dosage Form
CAPSULE
Route
ORAL
Marketing Status
Application #
NDA021938
Marketing Start
01/26/2006

Recall History

2 Recalls on Record
Class II04/03/2018

Kroger Specialty Pharmacy, Inc.

Lack of Processing Controls.

TerminatedVoluntary: Firm initiated
Class II04/03/2018

Kroger Specialty Pharmacy, Inc.

Lack of Processing Controls.

TerminatedVoluntary: Firm initiated

Frequently Asked Questions

What is SUTENT used for?

SUTENT contains Sunitinib malate. It is a capsule taken oral. Consult your doctor for specific uses.

Is SUTENT a controlled substance?

SUTENT is not classified as a controlled substance by the DEA.

What is the generic name for SUTENT?

The generic name for SUTENT is Sunitinib malate. There are 11 other brand versions of Sunitinib malate.

What is the NDC code for SUTENT 12.5 mg/1?

The NDC (National Drug Code) for SUTENT 12.5 mg/1 is 63539-017, listed by U.S. Pharmaceuticals.